Belgium
Imcyse concludes enrolment in Type 1 diabetes therapy trial
Topline results from the Phase II clinical trial are expected in the first quarter of next year.
UCB reports positive data from two hidradenitis suppurativa therapy trials
North America sees hiring increase in clinical trial operations fintech roles
Celyad to halt Phase Ib trial of CAR T therapy for colorectal cancer
Precirix begins subject dosing in Phase I/II cancer therapy trial
ExeVir enrols first subject in Phase Ib/II trial of Covid antiviral therapy
ExeVir doses first participants in Phase I Covid-19 antibody trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
